Equitable Access: Distributing Diagnostics and Medicines Fairly

The shift

Health systems are moving away from centralised procurement models that concentrate diagnostics and medicines in urban hubs toward distributed networks that prioritise remote and low-resource sites. This shift places point-of-care testing and essential drug stocks closer to primary-care teams so that decisions about treatment begin at first contact rather than after long referral delays. Operators now track inventory in real time across facilities so that stock-outs trigger automatic replenishment rather than waiting for quarterly orders. Clinicians see the change in daily practice as rapid antigen panels and basic chemistry cartridges arrive alongside the medicines they support, reducing the gap between diagnosis and therapy. The underlying principle is that geography or income should not determine whether a patient receives a confirmed result or an appropriate prescription. Training programmes now include supply-chain literacy so that physicians and nurses can flag distribution shortfalls before they become clinical emergencies. This transition demands coordination between ministries, manufacturers, and local health posts to maintain cold-chain integrity and accurate forecasting without relying on ad-hoc donations.

How it works in clinic

In daily practice a clinician opens a shared digital dashboard that shows current stock of rapid diagnostic tests and first-line medicines at the facility and at the nearest hub. When a patient presents with fever or respiratory symptoms the clinician selects the appropriate cartridge from the on-site kit, runs the test, and records the result directly into the same system that alerts the pharmacy for medicine release. If the test indicates a need for a medicine that is low in stock, the platform generates an order that travels to the regional depot with a projected delivery window visible to the care team. Follow-up visits are scheduled only after confirmation that the medicine has arrived, avoiding wasted trips for patients. Documentation of every test and prescription feeds into anonymised utilisation reports that help adjust future allocations. The workflow keeps the clinician focused on interpretation and counselling while the logistics layer handles movement of goods. Regular huddles review any mismatches between test results ordered and medicines dispensed so that patterns of inequity surface quickly and can be corrected at the facility level.

Who pays

Payment flows through blended public and pooled mechanisms that separate the cost of the diagnostic from the cost of the medicine. National health budgets underwrite core lists of tests and essential medicines while development partners underwrite surge capacity during outbreaks or seasonal spikes. Facilities receive capitation or results-based payments that include a line item for consumables rather than requiring patients to purchase items out of pocket. Pooled procurement across districts lowers unit costs and creates predictable demand signals for manufacturers, encouraging them to maintain regional buffer stocks. When a test and its companion medicine are bundled in the payment model, the incentive to withhold one or the other disappears. Revenue from insured patients subsidises services for the uninsured within the same facility, maintaining clinical flow without visible two-tier care. Operators monitor payment delays to ensure that suppliers continue deliveries even when reimbursement cycles lag.

Where it fails

Distribution breaks when last-mile transport cannot maintain temperature control or when customs clearance for reagents stretches beyond shelf-life limits. Regulatory pathways that treat every new diagnostic as a novel device rather than an extension of an existing platform create months-long approval gaps that leave rural clinics without updated tests. Clinician training often stops at device operation and never reaches inventory management, so staff do not reorder until shelves are empty. Data systems that do not talk to one another produce duplicate orders or invisible stock sitting in one district while another faces shortages. Corruption in tendering processes diverts medicines to private markets, and weak accountability leaves facilities without recourse. Patients who travel long distances for a test still encounter stock-outs of the medicine that the test indicates, forcing them to restart the journey elsewhere. These failures compound when facilities lack authority to shift stock laterally without central approval.

A named country or system

India’s public health supply chain illustrates both progress and persistent friction. State-level warehouses feed district stores that in turn supply primary health centres, yet monsoon disruptions and road quality still isolate some blocks for weeks. The introduction of e-Aushadhi-style platforms has allowed facility staff to view stock across neighbouring centres and request transfers, shortening the time between a positive test and medicine availability. National essential-medicine lists guide procurement, but state variations in tendering speed mean some regions receive new diagnostic lots months ahead of others. Community health workers now carry limited rapid tests and can trigger resupply through the same digital channel used by physicians, extending reach without expanding clinic walls. Persistent gaps remain in cold-chain coverage for certain reagents and in synchronising diagnostic and medicine deliveries so that a confirmed case does not wait for the drug to arrive.

What to do this quarter

Map every diagnostic and its companion medicine on a single facility sheet and mark items whose stock falls below a two-week threshold. Establish a weekly call with the district depot to confirm delivery dates and identify any items at risk of expiry before use. Train one staff member to run the inventory dashboard and to escalate mismatches between test cartridges and medicines within 24 hours. Review the last three months of referral slips to see how many patients were sent elsewhere because a test or medicine was unavailable locally. Create a simple paper back-up log for days when connectivity drops so that orders are not lost. Share the resulting gap list with neighbouring facilities to explore lateral transfers before central requests are filed.

Three moves

• Align test menus with medicine formularies at every site so that results trigger immediate dispensing.
• Require joint forecasting of diagnostics and medicines in quarterly budgets to prevent orphaned tests.
• Mandate visible stock dashboards in every clinic so clinicians can act before shortages reach patients.

LetsGo.Health provides the coordination layer that turns these equity principles into daily operational reality for clinicians and supply teams.